Ms. Shonta Chambers

Ms. Shonta Chambers

Executive Vice President of Health Equity Initiatives and Community Engagement

Executive Vice President of Health Equity Initiatives and Community Engagement

Patient Advocate Foundation (PAF)

Ms. Shonta Chambers transitioned back to the non-profit sector in 2014 by joining PAF. She leads the development and execution of strategic initiatives to expand PAF’s approach to achieve health equity through community and national level partnership engagement and mobilization. These initiatives are designed to link limited income communities to resources to abate financial, logistical and social access to care barriers. She brings to this role nearly 20 years of non-profit and public sector middle and senior level experience that spans public health, women’s health and behavioral health.

Additionally, she serves as the Principal Investigator on record as part of DP13-1314 CDC’s National Networks to Reduce Cancer and Tobacco Related Disparities Cooperative Agreement. In this role, she administers the SelfMade Health Network a national network focused on reducing cancer and tobacco related disparities among populations with low socio-economic characteristics.

Shonta enjoys mentoring young women, golf, and watching her sons play baseball.

Dr. Arnav Srivastava

Dr. Arnav Srivastava

Urologic Oncologist

Urologic Oncologist

University of Michigan

Dr. Arnav Srivastava is an urologic oncology fellow at the University of Michigan. He obtained his MD, MPH from The Johns Hopkins University School of Medicine in Baltimore, MD. He then completed his urology residency at Rutgers Robert Wood Johnson University Hospital in New Brunswick, NJ.

He has clinical interests in urologic malignancies including prostate, bladder, and kidney cancer.

He has research interests in health services research, health economics, insurance design, and biomarker development.

He has more than 50 publications and over 1000 citings.

Mr. Ira Goldman

Mr. Ira Goldman

Vice President, Global Public Policy and Government Relations

Vice President, Global Public Policy and Government Relations

Lantheus

Ira N. Goldman is Vice President, Global Public Policy and Government Relations, Lantheus Holdings. He is Co-Chair of the Isotope Supply Committee, Council on Radioisotopes and Radiopharmaceuticals (CORAR) and Vice-Chairman of the Security of Supply Working Group, Nuclear Medicine Europe.

Mr. Goldman is responsible for development and execution of Lantheus’s strategy and actions for public and healthcare policy, including legislative strategy and interactions with the U.S. Congress as well as relationships with Executive Branch agencies. He coordinates Lantheus’s involvement with trade associations, business and regional advocacy groups and medical societies. He also interacts with U.S. and foreign governments and international organizations regarding medical isotope production and supply matters.    

Mr Goldman was Scientific Officer in the IAEA Department of Nuclear Energy, Division of Nuclear Fuel Cycle and Waste Technology dealing with research reactor issues, including technical and policy matters. These activities covered conversion of research reactor fuel and medical isotope production targets from HEU to low-enriched uranium (LEU), research reactor fuel repatriation programmes, and research reactor fuel cycle economic analysis. Mr. Goldman was responsible for a number of IAEA activities related to the Global Threat Reduction Initiative (GTRI) and for planning, preparation, conduct and follow-up of international scientific meetings and Coordinated Research Projects (CRPs) involving scientific institutions of developed and developing countries. 

Mr Goldman was Science Attache, U.S. Mission to International Organizations in Vienna, Austria (1996-2004), from the Department of Energy (DOE), National Nuclear Security Administration (NNSA). He interacted with three major IAEA programmes, including radioisotopes and nuclear medicine, nuclear energy, waste management and the fuel cycle and technical cooperation. He was responsible for overseeing $20 million in U.S. extrabudgetary contributions to the IAEA and for interactions with senior U.S., DOE, IAEA, and foreign government officials.

Mr Goldman also worked at U.S. DOE, Washington, D.C., in the Office of Arms Control and Non-Proliferation, International Safeguards Division (1992-1996) as coordinator for IAEA activities and served as the DOE representative to the U.S. Delegation to the Nuclear Non-Proliferation (NPT) Review and Extension Conference (1995). He also worked at the U.S. Arms Control and Disarmament Agency (now U.S. Department of State, 1985-1992); and as Senior Policy Analyst at the Meridian Corporation (now Dyncorp, 1981-1985); and at the Congressional Research Service of the Library of Congress (1980-1981).

Mr Goldman earned a Master of Arts in International Affairs (with distinction) from the Johns Hopkins University Nitze School of Advanced International Studies in Washington DC in 1980, including study at the Johns Hopkins Centre for European Studies in Bologna, Italy (1978-1979). Mr Goldman earned a Bachelor of Arts (with honours) in History and was Phi Beta Kappa at Trinity College, Hartford, Connecticut in 1978.

Ms. Tomeeka Miller

Ms. Tomeeka Miller

Assistant to the President

Assistant to the President

PHEN

Ms. Tomeeka Miller is no stranger to PHEN’s mission to eliminate the Black prostate cancer disparity, as she played a pivotal role when the organization was founded when her company, Spotlight Communications supported PHEN’s marketing, event strategy, and publicity of the very first African American Prostate Cancer Disparity Summit in 2005. She also helped publicize Thomas A. Farrington’s book, “Battling the Killer Within” as well as promoting the Rally Against Prostate Cancer in partnership with sponsors and church partners to an audience reach of over 20 million. 

As assistant to the President, Tomeeka brings over 20 years of experience in developing and executing strategic communications programs that drive results for nonprofits, federal agencies, and Fortune 100 companies. She built her own marketing company to over $1M in gross revenues and was also named a Boston Business Journal 40 under 40 honoree. Most recently, she led digital and social media teams for Liberty Mutual and USAA, to help better connect digital products with customers.  

Tomeeka holds a master’s degree in journalism and public Affairs from the American University, a bachelor’s degree from Boston College, and an Executive MBA from UMass Boston.

She is a proud army spouse and resides in Charlotte, NC with her husband, Isaac, 6-year-old daughter, London, 16-year-old son, Ethan, and hound dog, Chase. Tomeeka loves cycling and any type of HIIT exercise to help her keep up with the demands of her active family.

 

Mr. Anthony “Tony” Hill Sr

Mr. Anthony “Tony” Hill Sr

Former Senator, PHEN Policy Coordinator

Former Senator, PHEN Policy Coordinator

PHEN

Anthony C. “Tony” Hill, Sr. is a prostate cancer survivor and serves as PHEN’ s Policy Coordinator.

Tony Hill was born September 9, 1957. Former Florida State Senator, Dr. Tony Hill, served as Field Representative for former US Congressman Al Lawson, Jr of Florida. He previously served as Federal Policy Director for former Jacksonville, FL Mayor Alvin Brown. He is a Life Member of Omega Psi Phi Fraternity, Inc. (Theta Phi Chapter) and holds numerous other prestigious honors including Chair of the NAACP Florida State Conference Labor Roundtable, Founder of the Achieve, Instill & Inspire Foundation, which provides scholarships for African American and Latino males to attend college in the field of education. Senator Hill currently holds two Honorary Doctorate of Law degrees, the first from Edward Waters College in 1995 and most recently from Bethune-Cookman University. He received a rare and prestigious honor and joined the ranks of a select group of men when inducted into the historic Montford Point Marine Association Hall of Fame.

Senator Hill is a former Florida State Senator. Elected initially in November 2002, he was subsequently re- elected to a four-year-term in 2004 when he chaired the Florida Minimum Wage Ballot Initiative, which provided a $1.00 per hour raise to the minimum wage and increased the index. As a direct result of this vital legislation, the working poor now receive an automatic increase to the minimum wage each time the economy grows. He was the first African American to represent Volusia County (Daytona Beach) in the State Senate. Senator Hill also served as the former Senate Democratic Floor Leader, the third-ranking member of the Democratic Party leadership in the Senate. In this role, he was responsible for gathering votes on major issues.

A graduate of Jean Ribault Senior High School in Jacksonville, Tony Hill attended Lincoln University, in Lincoln, Pennsylvania and graduated from the National Labor College in Silver Spring, Maryland; earning a B.A. Degree in Labor Studies. Senator Hill delivered the final commencement address of the historic presidency of Dr. Trudy Kibbe Reed, the fifth president and only second woman to serve in this capacity in the 108-year history of Bethune-Cookman University.

A man of commitment and service, Senator Hill also inspires and leads those in the household of faith as long- standing member of the Greater Macedonia Baptist Church, where he Served as a Deacon, teaches Sunday School and is the founder and chair of the Men’s Usher Board.

Senator Hill is a humble man committed to positively influencing those around him. His legacy of service is a testament to his faith and a symbol of his desire to inspire by actively pouring into the lives of others so that they too can know the definition of Leadership at every level!

Ms. Amy Worth

Ms. Amy Worth

Associate Director in Clinical Operations

Associate Director in Clinical Operations

Macrogenics

Ms. Amy Worth is an Associate Director in Clinical Operations at MacroGenics. She manages oversight of clinical trials, with a strong focus on patient engagement and diverse recruitment. Her hybrid role supports the implementation of new strategies previously unexplored at MacroGenics with ‘patient focus’ front of mind. In addition, Amy’s unique position enables her to observe the impact implementation of innovative strategies on site quality, recruitment, and retention. Amy is passionate about engaging the people most impacted by innovation [patients] into MacroGenics’ clinical development process.  Amy has had the privilege of collaborating with patient advocacy groups, like PHEN, and understands the importance of community involvement and meaningful relationships to further clinical trial diversification, education, and awareness.